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ABSTRACT 
In an observational longitudinal study, there can be time-varying 
exposure/treatment and time-varying confounders. When the confounders affect the 
exposure and prior exposure also has an impact on levels of confounders, there is 
treatment confounder feedback. To admit estimation of unbiased causal effects, these 
conditions need to be hold, exchangeability, positivity, consistency. The traditional 
method of conditioning on potential confounders does not meet these 3 conditions. 
Therefore, parameter estimates from traditional Cox model are biased casual effect 
estimates when the treatment confounder feedback exists. The marginal structural 
Cox model can be used to address this issue. By calculating and including inverse 
probability (IP) weights, the impact of confounding can be removed. Estimates from 
models with IP weights are interpreted as the causal effect that comparing always in 
treatment group vs. never in treatment group.  
In this study, first, I introduced basic concepts of causal inference, treatment 
confounder feedback and the marginal structural model; detailed steps of calculating 
IP weights and model fitting. In simulation study, I compared the time-dependent Cox 
models and the marginal structural Cox model; Also, for the marginal model, results 
using three types of IP weights were compared: un-stabilized weight, stabilized weight, 
and stabilized weight considering censoring. Performance metrics of each method 
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were evaluated based on their bias, percentage bias, empirical standard deviation, 
standard error and coverage probability of 95% confidence intervals. Aerobics Center 
Longitudinal Study (ACLS) data were used to explore the causal effect of 
cardiorespiratory fitness on hypertension incidence. Overweight or obese is a risk 
factor of hypertension. We hypothesized that cardiorespiratory fitness may help lower 
BMI via physical exercise, while reduced BMI or improved overweight status may 
promote cardiorespiratory fitness. Thus, there exists cardiorespiratory (treatment) 
overweight (confounder) feedback, and the marginal structural Cox model may 
deepen our understanding of association between hypertension and CRF through ACLS 
data. 
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CHAPTER 1 
INTRODUCTION 
1.1 CAUSAL INFERENCE 
To explore the effect of an intervention on an outcome, ideally, we want to 
have outcomes of subjects with intervention and outcomes of the same subjects 
without intervention. Then the intervention effect would be the difference under two 
intervention conditions. Usually, we don’t observe both outcomes. So, there have 
been many different proposed techniques, like randomization and matching to 
compare 2 groups of subjects (with and without exposure). Under various approaches, 
the difference between treatment groups is reasonable to represent the true effect of 
the intervention.  
Let random variable A be a binary treatment, and let a represent the value of A 
(a=1 as treated, and a=0 as untreated). Further, let Y represent the observed outcome 
and L represent a vector of confounders. Ya=1 is defined as the counterfactual outcome 
over all subjects in the population had they been treated. Ya=0 is defined as the 
counterfactual outcome over all subjects in the population had they been untreated. 
The average causal effect in population is defined as E[Ya=1]-E[Ya=0]. Because definition 
is not conditional on other variables, it is also called marginal causal effect. (1) 
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In randomized clinical trials, randomization can eliminate the effect of 
confounding, so results can be explained as causal effect. In an observational study, 
when the confounding is controlled, the conditional effect is a consistent estimator of 
the causal effect, E[Y=1|a=1] =E[Ya=1]. To get an unbiased estimate of the casual effect 
from an observational study, three assumptions need to hold (2): 
1) Exchangeability: 
Participants with treatment would have the same outcome as those without 
treatment had they not received the treatment. Similarly, participants without 
treatment would have the same outcome (as those with treatment) had they received 
the treatment. In other words, the observed treatment status is independent of 
counterfactual outcome, Ya is independent of A, for all a. 
2) Positivity: 
It is impossible to get the average effect of treatment, if all participants are in 
treatment group, or all people are untreated. A positive probability of accepting all 
treatment levels is required. Pr[A=a|L=l] >0, for all l with Pr[L=l] not equal to 0. 
3) Consistency: 
The observed outcome under the observed treatment status equals the 
counterfactual outcome of the observed treatment status. If A=a, then Y=Ya. 
1.2 TIME-VARYING TREATMENT AND CONFOUNDERS 
In a longitudinal study, we have time-varying treatment and time-varying 
confounders. Robins first introduced the effects of time-varying treatments in 
observational studies in 1986. (3) Suppose there are m+1 visits in the longitudinal 
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study. Let Aj be the time-varying treatment at time j (j=0, 1, 2, ..., m), Lj be the vector of 
time-varying confounders, Y be the outcome observed at time m+1. Allowing an 
overbar to denote the history, ?̅?𝑗 is then the history of treatment, ?̅?𝑗= (A0, A1, ...Aj);  ?̅?𝑗 
is the history of confounders ?̅?𝑗= (L0, L1, ...Lj). The lowercase letters represent the value 
of random variables. For binary treatment, if the treatment=1 at all visits, that is ?̅?𝑗 = 
(1, 1, ..., 1), then it is "always treat". On the other hand, if ?̅?𝑗 = (0, 0, ..., 0), then it is 
"never treat”. The marginal causal effect is defined as the difference between the 
above 2 counterfactual effects (always treat vs. never treat), 𝐸(𝑌?̅?=1̅) − 𝐸(𝑌?̅?=0̅). (4) 
Extending to time-varying treatments, to achieve valid causal inferences, all 
three conditions described in previous section need to hold. At each visit, if the time-
varying treatment is unconfounded conditional on previous treatment history and 
confounders history, then exchangeability holds. Thus, at each time point, conditional 
exchangeability holds. It can also be called sequential exchangeability. 
Sequential positivity is defined as, 
Pr(𝐴𝑗 = 𝑎𝑗| ?̅?𝑗−1 = ?̅?𝑗−1, ?̅?𝑗 = 𝑙?̅?) > 0 , for all ?̅?𝑗 and 𝑙?̅?, if 𝑃𝑟(?̅?𝑗−1 = ?̅?𝑗−1, ?̅?𝑗 = 𝑙?̅?) ≠ 0. 
Sequential consistency is defined as, 
If ?̅? = ?̅?, then 𝑌 = 𝑌?̅?. If ?̅?𝑗−1 = ?̅?𝑗−1, then ?̅?𝑗 = ?̅?𝑗
?̅?. (4) 
1.3 TREATMENT CONFOUNDER FEEDBACK 
In a longitudinal study, variables are observed repeatedly. At each time point, 
there is a set of observations including treatment and potential confounders. However, 
their relationship might complicate the analysis. When the confounders affect the 
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treatment and previous treatment also affects levels of confounders, there is 
treatment confounder feedback. (5) 
For example, in the Aerobics Center Longitudinal Study (ACLS), to investigate 
the effect of cardiorespiratory fitness (CRF) on hypertension incidence, participants 
were enrolled and were followed up from 1974 to2003. Details of ACLS study were 
described in Chapter 4. At each visit, information collected included age, sex, CRF, 
body mass index (BMI), smoking and heavy drinking status, family history of 
hypertension, diagnosis of hypertension, diabetes and hypercholesterolemia, etc. 
Overweight or obese is a risk factor of hypertension. The improved overweight or 
obese status will help increase CRF level. On the other hand, increased CRF level 
caused by the increased physical activity help reduce body fat percentage, BMI and 
change the overweight status. Therefore, there is treatment confounder feedback.  
1.4 TIME DEPENDENT COX MODEL AND WHY FAIL 
In the survival analysis setting, to estimate the effect of treatment on the 
outcome, one may estimate a time-dependent Cox model with baseline confounders. 
Another way is modeling the time-dependent Cox model with time-varying 
confounders. 
Let 𝐴𝑗 be the time-dependent exposure,  𝐿0 be the baseline covariate vectors, 
and 𝐿𝑗 be the time-varying covariate vectors. 𝜆0(𝑗) is the baseline hazard function. 
Model with baseline covariates, 
𝜆(𝑗|𝑍(𝑗)) = 𝜆0(𝑗) exp(𝜷𝒁(𝒋)) = 𝜆0(𝑗) exp(𝜷𝟏𝑨𝒋 +  𝜷𝟐𝑳𝟎 ) 
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Model with time-varying covariates, 
𝜆(𝑗|𝑍(𝑗)) = 𝜆0(𝑗) exp(𝜷𝒁(𝒋)) = 𝜆0(𝑗) exp(𝜷𝟑𝑨𝒋 +  𝜷𝟒𝑳𝒋 ) 
exp(𝛽1) is the constant hazard ratio of the exposure conditional on levels of 
baseline covariates. exp(𝜷3) is the hazard ratio of the exposure conditional on levels 
of covariates at time j. 
To estimate the parameter 𝜷, the partial likelihood method is used. The partial 
likelihood can be treated as the product of conditional probability that subject i fails 
from the risk set at time 𝑱𝒊. The partial likelihood is: 
𝐿(𝜷) = ∏  [  
𝒆𝒙𝒑 {𝜷𝒁𝒊(𝑱𝒊)}
∑ 𝒆𝒙𝒑 {𝜷𝒁𝒕(𝑱𝒊)}𝒕∈𝑹(𝒋≥𝑱𝒊)
  ]
𝜹𝒊𝒏
𝒊=𝟏
 
where 𝑅(𝑗 ≥ 𝐽𝑖) is the risk set at time 𝐽𝑖, and  𝛿𝑖 (1=censored and 0=uncensored) is the 
censor status at time 𝐽𝑖. It is the product of conditional probability that subject i fails 
from the risk set at time 𝐽𝑖. 
By solving the derivative of log[L(β)=0], the solution, denoted as ?̂?, is the 
maximum likelihood estimate of parameter β. The hazard at time j depends on the 
variable of treatment and confounders at that time. The regression effect of treatment 
A and confounders L are constant over time.  
The time dependent Cox model with baseline confounders only uses the 
baseline information, and the confounding can't be fully controlled. Thus, the 
estimation effect from this model would be biased.  
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For the time-dependent Cox model using time-varying confounders, by simply 
adjusting for the time-varying confounders, at each visit, sequential exchangeability 
would not hold. This is because the confounder at time j is influenced by previous 
exposure or treatment. (5) 
Marginal structural Cox models (MSMs) can be used to get the causal inference 
of treatment in the presence of treatment confounder feedback. An early variant of an 
MSM was developed by Dr. Marian Pugh in 1993, to solve the problem of missing data. 
(6) Dr. James Robins and Miguel Hernán from Harvard first published the general 
approach in 1999. (7) The idea is to apply weights to eliminate the confounding on 
treatment and/or censoring (in survival setting), thus allowing unbiased causal effects 
to be estimated. Marginal means the model estimates the marginal distribution 
instead of the conditional distribution. Structural refers to the causal inference.  
1.5 OUTLINE OF THESIS 
The main aim of this thesis is to understand the marginal structural Cox model 
and to apply this model in real data analysis. 
In Chapter 2, we will explain the inverse probability (IP) weighting and the 
marginal structural Cox model. In Chapter 3, there is a simulation study and 
comparisons are made between the results of a traditional time-dependent Cox model 
and a marginal structural Cox model. In Chapter 4, we will apply this method using the 
Aerobics Center Longitudinal Study (ACLS) data. In Chapter 5, there is discussion and 
conclusion. 
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CHAPTER 2 
IP WEIGHTING AND MARGINAL STRUCTURAL COX MODEL 
2.1 IP WEIGHTING  
Inverse probability (IP) weighting is a method commonly used in survey 
sampling to adjust for the sample selection process and get unbiased estimates. (8, 9) 
Each observation is weighted by the reciprocal of the predicted probability of the 
observed exposure status. There are 2 properties of IP weighting. First, using IP 
weights, exposure is unconfounded. Second, the effect of exposure on outcome is the 
same as in the true study population. (10) To briefly explain the idea of IP weighting, I 
simulated data with variable exposure, sex and outcome Y (sample size=2000). The 
distribution of sex is not balanced for two exposure groups. 
First, binary variable exposure (Yes=1 vs. No=0) was generated based on 
binomial distribution (n=2000, p=0.5). For exposed group, sex (women=1 vs. men=0) 
was generated based on binomial with p=0.3; while for unexposed group, sex was on 
binomial with p=0.7. Error was generated based on normal distribution with mean 
being 0 and variance being 0.01. Outcome Ys equal to the sum of intercept (true value 
0.5), effect of sex (true value 0.2 times sex), effect of exposure (true value -0.6 times  
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exposure) and random error. 𝑌 = 0.5 + 0.2 ∗ 𝑓𝑒𝑚𝑎𝑙𝑒 − 0.6 ∗ 𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒 + 𝑒𝑟𝑟𝑜𝑟 
As Table 2.1, in unweighted count, the sex distribution between two exposure groups 
was different, so sex might be a confounder. IPW weight was calculated as 1/Pr 
[exposure| sex]. For example, the weight for men in unexposed group was 3.29, which 
meant contributing 3.29 times observation in pseudo population, that it 
306*3.29=1006. By adjusting for weights, the distribution of sex between two groups 
was balanced. If we conduct linear regression of Y on exposure, in unweighted case, 
the estimated effect of exposure was biased (point estimate -0.68). However, after 
adjusting for weights, the estimated effect was not biased (point estimate -0.60). 
Table 2.1 Sex distribution between unexposed and exposed groups 
 
Men Women 
Unweighted count   
Unexposed 306 (30.42%) 700 (70.42%) 
Exposed 700 (69.58%) 294 (29.58%) 
Weights 
  Unexposed 3.29 1.42 
Exposed 1.44 3.38 
Weighted count 
  Unexposed 1006 (50%) 994 (50%) 
Exposed 1006 (50%) 994 (50%) 
 
 
There are different ways of calculating the weight. Weights should be chosen 
so that 1) the exposure is unconfounded; 2) effects in pseudo population are the same 
as in the true study population; and 3) weights are ‘’as close as possible to 1” to 
prevent extreme weights and reduce variance. (10) 
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In the context of time-dependent treatment, the weights are time-varying at 
different observed times or visits for the same subject. From the start (j=0) to the end 
of follow-up (j=m), IP weighting is based on the overall probability of the subject 
receiving his or her own observed history of treatment 𝐴𝑗=0to 𝐴𝑗=𝑚, the product of 
visit specific probabilities. According to published papers, different calculations lead to 
weights that are either un-stabilized or stabilized. (1, 10, 11) An un-stabilized weight is 
the inverse of the estimated probability that a subject received the observed 
treatment, given the baseline covariates 𝐿0 (not time-varying), history of treatments 
up to visit time j-1, ?̅?𝑗−1, and history of confounder up to visit time j, ?̅?𝑗. If the 
probability is small, then the inverse of probability would be large and large weights 
lead to unstable results. 
 
Stabilized weights of treatment have the same denominator, instead of 1 as the 
numerator, it uses the estimated probability that a subject received the observed 
treatment, given the baseline covariates and history of treatments up to visit time j-1. 
History of confounder was not included. In this way, the variability of stabilized 
weights is smaller and the resulting calculations of the weights are much closer to 1. 
 
The right censoring is very common to be seen in survival data, which is caused 
by lost to follow up or the end of study. Most of time, we assume that censoring is 
informative. Applying the same idea of dealing confounders by weights, weights can 
𝑤𝑚
𝑇 = ∏
1
Pr (𝐴𝑗 = 𝑎𝑗|?̅?𝑗−1 = ?̅?𝑗−1, 𝐿0 = 𝑙0,  ?̅?𝑗 = 𝑙?̅?)
𝑚
𝑗=0
 
𝑠𝑤𝑚
𝑇 = ∏
Pr (𝐴𝑗 = 𝑎𝑗|?̅?𝑗−1 = ?̅?𝑗−1, 𝐿0 = 𝑙0)
Pr (𝐴𝑗 = 𝑎𝑗|?̅?𝑗−1 = ?̅?𝑗−1, 𝐿0 = 𝑙0,  ?̅?𝑗 = 𝑙?̅?)
𝑚
𝑗=0
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solve the problems of informative censoring. The denominator of stabilized weights for 
censoring is the probability of subjects not censored at time j, given their treatment 
history till j-1, baseline covariates, and the history of confounder up to time j-1. The 
numerator is the probability without further conditional on the history of the 
confounder. The final stabilized weights are product of stabilized weights of treatment 
and censor, 𝑠𝑤𝑚
𝑇 × 𝑠𝑤𝑚
𝐶. 
 
 
The treatment can be binary, multinomial, and continuous. The inverse 
probability weights can be calculated from different models. For example, to fit the 
pooled logistic regression for binary treatment; to fit the multinomial regression for 
categorical treatment. Next, we introduce the detailed calculation of stabilized weights 
of treatment and censoring by fitting four pooled logistic models. 
Step 1: Data preparation. Data are organized into the long format (for each 
subject, there are multiple rows of observations – one observation per time period). 
Variables include participants’ ID, start time of each visit 𝑇𝑗, end time of visit 𝑇𝑗+1, 
exposure at the start of the visit interval 𝐴𝑗 , potential confounders (time-independent 
confounders 𝐿0 and time-varying confounders 𝐿𝑗), censor indicator𝐶𝑗, and outcomes 𝑌𝑗.  
Step 2: Fitting pooled logistic models and getting the estimated probability. 
Model 1: logit pr(Aj =1) = A̅j−1  +  L0 . If the observed treatment Aj = 1, then the 
estimated probability of the observed treatment equals to the probability of treatment 
𝑠𝑤𝑚
𝐶 = ∏
Pr (𝐶𝑗 = 0|𝐶?̅?−1 = 0, ?̅?𝑗−1 = ?̅?𝑗−1, 𝐿0 = 𝑙0)
Pr (𝐶𝑗 = 0|𝐶?̅?−1 = 0, ?̅?𝑗−1 = ?̅?𝑗−1, 𝐿0 = 𝑙0,  ?̅?𝑗−1 = 𝑙?̅?−1)
𝑚
𝑗=0
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at time j. If Aj = 0, then the estimated probability of the observed treatment equals to 
1 minus the estimated probability of treatment. Model 2:  logit pr(Aj =1) = A̅j−1  +
 L0 + L̅j.  Model 3: logit pr(Cj = 0) = A̅j−1  +  L0. We assume that once subjects are 
censored, they will not come back to the study. We estimate the probability that a 
subject remains uncensored at time j. Model 4: logit pr(Cj =1) = A̅j−1  +  L0 + L̅j−1. 
Step 3: Combing weights of treatment and censoring. The numerator of the 
stabilized weights 𝑠𝑤𝑚
𝑇 × 𝑠𝑤𝑚
𝐶, can be estimated by multiplying the estimated 
probability of the observed treatment at time j (from Model 1) and probability of 
remaining uncensored till time j (from Model 3). The denominator of the weights can 
be estimated by multiplying the estimated probability from Model 2 and Model 4.   
Step 4: So far, weights are calculated at each time point during follow-up. In 
the final step, we need to calculate the cumulative product over all previous times up 
to j. For example, weights at time 3, are production of estimated 𝑠𝑤𝑚
𝑇 × 𝑠𝑤𝑚
𝐶  
(results of step 3) at time 1, time 2 and time 3. Weight at time 5 are production of 
weights of the first 5 times.  
If the models to estimate the weights are correctly specified, then by 
incorporated the calculated weight into the final model of interest, the confounding of 
treatment and censor will be eliminated.  
To estimate the inverse probability weights, there is an R package “ipw”. For 
longitudinal data, the iptm function can compute weights at each time point during 
12 
 
follow-up. The exposure can be continuous, binomial, multinomial, or ordinal. Both 
stabilized and un-stabilized weights can be estimated.  
2.2 MARGINAL STRUCTURAL COX MODEL 
By using IP weights, the confounding due to time-dependent covariates is 
removed, and the hazard function of the marginal structural Cox model is as follows, 
𝜆𝐽?̅? = 𝜆0(𝑗) exp(𝛽1𝐴𝑗) 
Parameter β can be estimated using the partial likelihood method. 95% 
confidence interval for β can be calculated using bootstrap methods or by computing 
analytic variance estimates, or using robust variance estimates. 
?̂? ± 1.96 × √𝑣𝑎𝑟(𝛽)̂  
The outcome variable of marginal Cox model is a counterfactual since it uses 
the pseudo-population. Therefore, it is called structural mean model. The IP weighted 
estimates causation of the marginal structural model. Parameters can be interpreted 
as the mean hazard ratio of event if everybody was always treated comparing to if 
everybody was never being treated.
13 
 
CHAPTER 3. SIMULATION STUDY 
The aims of this chapter are: Firstly, to compare the estimates from the time 
dependent Cox models and the marginal structural Cox model. Another aim is to 
compare the performance of un-stabilized weights and stabilized weights in the 
marginal structural model. In addition, we will check how estimates vary when the 
sample size, censoring rate or the true effects change.  
3.1 GENERATING AND PREPARING DATA 
500 samples, each with n subjects (n=500 or n=2500) and 10 visits were 
generated according to the algorithm described in Young et al (2008). (12) 
Corresponding SAS code is provided at https://cdn1.sPH.harvard.edu/wp-
content/uploads/sites/148/2012/10/simulate_snaftm.txt. 
For each sample,  
Step 1: Simulate the counterfactual 𝑇0 from an exponential distribution with 
scale parameter 𝜆0 (𝜆0 = 0.01 or 𝜆0 = 0.1). Define 𝐿−1 =  𝐴−1 = 𝑌0 = 0. For each j ϵ 
[0, 9] implement steps 2-4: 
Step 2: Simulate time varying confounders 𝐿𝑗 from 
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𝑙𝑜𝑔𝑖𝑡 [[Pr(𝐿𝑗 = 1|  ?̅?𝑗−1, ?̅?𝑗−1, 𝑇0, 𝑌𝑗 = 0; 𝜷)] = 𝛽0 + 𝛽1𝐼(𝑇0 < 𝑐) +
𝛽2𝐴𝑗−1 + 𝛽3𝐿𝑗−1，set 𝜷= (𝛽0, 𝛽1, 𝛽2, 𝛽3)=(log(3/7),2, log(1/2),log(3/2)) and c=30 
Step 3: Simulate 𝐴𝑗 from 𝑙𝑜𝑔𝑖𝑡[𝐴𝑗 = 1|?̅?𝑗 , ?̅?𝑗−1, 𝑌𝑗 = 0, 𝜶] = 𝛼0 + 𝛼1𝐿𝑗 +
𝛼2𝐿𝑗−1 +  𝛼3𝐴𝑗−1，set 𝜶= (𝛼0,𝛼1,𝛼2,𝛼3)=(log (2/7), 1/2, 1/2, log(4)) 
Step 4: simulate 𝑌𝑗+1and possible T 
If 𝑇0 > ∫ exp{𝜑𝑎 × 𝐴𝑚} 𝑑𝑚
𝑗+1
0
 then 𝑌𝑗+1=0;  
else 𝑌𝑗+1=1, T=𝑗 + (𝑇0 − ∫ exp{𝜑𝑎 × 𝐴𝑚} 𝑑𝑚
𝑗
0
) exp{−𝜑𝑎 × 𝐴𝑗} 
( 𝜑𝑎=0.3, 0 or -0.3) 
To explore the effect of sample size on effect estimation, for each sample, we 
generate n=500 subjects as an example of small sample size, and n=2500 subjects as an 
example of a large sample size.  For step 1, the counterfactual time was generated from 
an exponential distribution with constant rate of monthly events 𝜆0 throughout the 
follow-up. 𝜆0 = 0.01 is for rare incidence of event. 𝜆0 = 0.1 is for relatively common 
occurrence of event. It also defined that before the start of study, there is no 
confounder 𝐿−1 = 0, subjects are not treated 𝐴−1 = 0, remain uncensored and 
without event occurrence 𝑌0 = 0. 
Step 2 defines time varying confounders, which are affected by the previous 
treatment 𝐴𝑗−1 and confounders 𝐿𝑗−1. c is an arbitrary cutoff point, which affects the 
degree to which 𝑇0 affects 𝐿𝑗  for a chosen value of c. For step 3, treatment is affected 
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by confounders observed this time 𝐿𝑗 and previous time 𝐿𝑗−1, and previous treatment 
𝐴𝑗−1. In step 4, true value of marginal effect of treatment is 𝜑𝑎. Three values were 
simulated respectively, negative effect -0.3, null effect 0 and positive effect 0.3. 
From these data generation steps, we see that 𝐿𝑗 is associated with outcome 
𝑌𝑗+1 via indicator variable. 𝐿𝑗 predicts future treatment 𝐴𝑗  𝑎𝑛𝑑 𝐴𝑗+1; 𝐴𝑗−1 has an 
impact on 𝐿𝑗. There is treatment-confounder feedback. 
Data structure 
Table 3.1 shows the ‘long-format data structure. For each subject, there are at 
most 10 visits. For example, there are 10 visits for ID=1 and ID=2. Only 1 visit for ID=13, 
that is because the event occurs at time=0.93188. 7 visits for ID=20 because the event 
occurs at time=8.513671875. Time was cut into visit intervals from tpoint2 to tpoint, 0-
1, 1-2, 2-3, …, 9-10. During each time interval, A is the treatment status at the start of 
time, Am1 is the previous treatment; L is the confounder, Lm1 and Lm2 are the 
confounder history of previous 2 visits. Y is the binary outcome. If no event occurs at 
the end of the 10th time interval, this subject was censored, censor_r=1. Similarly, Ym is 
the outcome for the end of previous visits. T0 is the generated counterfactual time for 
censored subjects, T is the observed time for participants without censoring.  
Table 3.1 Example of long-formatted data structure 
ID A Am1 L Lm1 Lm2 Y Ym T T0 IT0 tpoint tpoint2 censor_r 
1 1 0 1 0 0 0 0 
 
21.140 1 1 0 0 
1 0 1 1 1 0 0 0 
 
21.140 1 2 1 0 
1 1 0 1 1 1 0 0 
 
21.140 1 3 2 0 
1 1 1 1 1 1 0 0 
 
21.140 1 4 3 0 
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1 1 1 0 1 1 0 0 
 
21.140 1 5 4 0 
1 0 1 1 0 1 0 0 
 
21.140 1 6 5 0 
1 0 0 1 1 0 0 0 
 
21.140 1 7 6 0 
1 0 0 1 1 1 0 0 
 
21.140 1 8 7 0 
1 0 0 1 1 1 0 0 
 
21.140 1 9 8 0 
1 0 0 0 1 1 0 0 
 
21.140 1 10 9 1 
2 0 0 0 0 0 0 0 
 
181.648 0 1 0 0 
2 1 0 1 0 0 0 0 
 
181.648 0 2 1 0 
2 1 1 1 1 0 0 0 
 
181.648 0 3 2 0 
2 0 1 1 1 1 0 0 
 
181.648 0 4 3 0 
2 1 0 0 1 1 0 0 
 
181.648 0 5 4 0 
2 1 1 0 0 1 0 0 
 
181.648 0 6 5 0 
2 1 1 1 0 0 0 0 
 
181.648 0 7 6 0 
2 0 1 0 1 0 0 0 
 
181.648 0 8 7 0 
2 1 0 0 0 1 0 0 
 
181.648 0 9 8 0 
2 0 1 0 0 0 0 0 
 
181.648 0 10 9 1 
13 1 0 1 0 0 1 0 0.932 0.932 1 1 0 0 
20 0 0 1 0 0 0 0 8.514 8.514 1 1 0 0 
20 0 0 1 1 0 0 0 8.514 8.514 1 2 1 0 
20 1 0 1 1 1 0 0 8.514 8.514 1 3 2 0 
20 1 1 0 1 1 0 0 8.514 8.514 1 4 3 0 
20 1 1 1 0 1 0 0 8.514 8.514 1 5 4 0 
20 1 1 1 1 0 0 0 8.514 8.514 1 6 5 0 
20 0 1 0 1 1 0 0 8.514 8.514 1 7 6 0 
20 0 0 1 0 1 0 0 8.514 8.514 1 8 7 0 
20 0 0 1 1 0 1 0 8.514 8.514 1 9 8 0 
 
 
3.2 COMPUTING WEIGHT 
A pooled logistic regression was fitted to estimate IP weights. Four models were 
fitted. Model 1 is for the numerator of 𝑠𝑤𝑚
𝑇, logit pr(A=1) = Am1; model 2 for 
denominator of 𝑠𝑤𝑚
𝑇, logit pr(A=1) = Am1+L+Lm1; Model 3 for numerator of 𝑠𝑤𝑚
𝐶 , 
logit pr(censor_r=0) =Am1; model 4 for denominator of 𝑠𝑤𝑚
𝐶, logit pr(censor_r=0) 
=Am1 + Lm1 +Lm2.  
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Predictions of treatment A from model 1 and 2 are estimated. To get the 
probability of observed treatment, we did the following calculation. If treatment A=1, 
then probability of observed treatment equals the prediction; if treatment A=0, then 
probability of observed treatment equals 1 minus the prediction. The time varying 
weight is the production of previous weight from the visit 1 to the end of current visit. 
Prediction of censoring is estimated from model 3 and 4. The time-varying weight for 
censoring is the production of previous weight from the first visit to the end of current 
visit. 
Three different weights are calculated, 
𝑤𝑚
𝑇 = ∏
1
𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛𝑠 𝑓𝑟𝑜𝑚 𝑚𝑜𝑑𝑒𝑙 2
𝑚
𝑗=0
 , 
𝑠𝑤𝑚
𝑇 = ∏
𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛𝑠 𝑓𝑟𝑜𝑚 𝑚𝑜𝑑𝑒𝑙 1
𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛𝑠 𝑓𝑟𝑜𝑚 𝑚𝑜𝑑𝑒𝑙 2
𝑚
𝑗=0
 , 
𝑠𝑤𝑚
𝑇 × 𝑠𝑤𝑚
𝐶 = ∏
𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛𝑠 𝑓𝑟𝑜𝑚 𝑚𝑜𝑑𝑒𝑙 1 𝑎𝑛𝑑 3 
𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛𝑠 𝑓𝑟𝑜𝑚 𝑚𝑜𝑑𝑒𝑙 2 𝑎𝑛𝑑 4
𝑚
𝑗=0
 . 
The SAS code is attached, please see Appendix A.  
3.3 MODEL FITTING 
The marginal Cox models with 3 different weights were fitted using function 
Coxph() in the R package ‘survival’. The dependent variable was the time and event 
status, and independent variable was treatment. Cluster () was specified to obtain 
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robust sandwich variance estimates of the coefficients. The Efron approximation was 
used for handling ties (multiple events at the same discrete time point).  
To compare results from the marginal structural Cox model, the time-
dependent Cox models were also fitted. One was a time-dependent model with 
baseline covariates L0. Another model was fitted using time-dependent confounder.  
In the longitudinal data, one subject has several observations. To get the 
variance of estimators, the interclass correlation needs to be considered because the 
observations are not independent. Due to the computational difficulty of getting the 
exact estimates of variance, the robust standard errors were estimated based on the 
modified sandwich variance estimator. Based on the normal approximation, the 95% 
confidence intervals can be computed by ± 1.96 times the robust standard error. The 
variance could also have been obtained by bootstrapping. However, that takes a 
considerable amount of time to run, so in this study, the robust variance estimates 
were used. 
3.4 PERFORMANCE METRICS 
The performance of different models was assessed by the following measures: 
Bias:  ∑ (𝜑?̂? − 𝜑)
𝑁
𝑖=1 /𝑁, the average difference between N (N=1000 for large 
sample size and N=500 for small sample size) estimated parameters and true value. 
Percentage Bias:  
𝐵𝑖𝑎𝑠
𝑇𝑟𝑢𝑒 𝑣𝑎𝑙𝑢𝑒 𝜑
× 100%. Only for true value -0.3 and 0.3. 
Empirical Standard Deviations: Standard deviation of N estimated parameters. 
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Standard Error: the average of N estimated standard errors of parameters. 
Means of Standard Error: 𝐵𝑖𝑎𝑠2 + Empirical Standard Deviation2 
Coverage Probability of 95% confidence intervals: proportion of N samples in 
which the true parameters are contained in the 95% confidence interval. 
3.5 RESULTS 
Results are listed in Table 3.2, 3.3 and 3.4. 
Models 
The marginal Cox model with stabilized weights 𝑠𝑤𝑚
𝑇 and 𝑠𝑤𝑚
𝑇 × 𝑠𝑤𝑚
𝐶  
performed better than the model using un-stabilized weights.  The model with two 
stabilized weights had smaller bias and empirical standard deviations, and the coverage 
probability reached around 95%. For the two marginal structural models with stabilized 
weights, bias, empirical standard deviations, standard error, MSE and coverage 
probability were comparable. Censoring in the generated data was not informative. 
When there is informative censoring, 𝑠𝑤𝑚
𝑇 × 𝑠𝑤𝑚
𝐶  is expected to behave better than 
𝑠𝑤𝑚
𝑇. 
For the two time-dependent Cox models, the model using time-varying 
covariates had smaller bias and bigger coverage than model using baseline covariates. 
However, the bias was still big and the real coverage probability didn’t reach 95%. 
Comparing estimates of marginal Cox model with time-dependent Cox models, 
marginal structural Cox models had smaller bias. The marginal models with stabilized 
weights and two time-dependent Cox models had similar empirical standard 
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deviations. Their empirical standard deviations were comparable to model based 
standard error, which indicated that the model fitted well. MSE was a combination of 
bias and empirical standard deviation. Marginal Cox model with stabilized weights 
𝑠𝑤𝑚
𝑇 and 𝑠𝑤𝑚
𝑇 × 𝑠𝑤𝑚
𝐶  had the smallest MSE. 
Sample size 
Comparing to the performance metrics in small sample size (n=500), results 
from large sample (n=2500) had smaller bias, empirical SD, model based SE, and MSE.  
Incidence rate of event 
The censoring rate in the simulated data is about 90% for rare event 𝜆0 = 0.01, 
and about 30%-40% for common event,  𝜆0 = 0.1. The coverage probability was larger 
for bigger incidence rate or smaller censoring rate. Especially, in the two time-varying 
Cox models, the coverage improved a lot when incidence rate increase from 0.01 to 
0.1. 
True effect of treatment 
Performance metrics of models were consistent in simulated data with three 
different true effect of treatment, null effect, positive and negative effects. Different true 
effects of exposure don't; impact the performance of models. 
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Table 3.2 Performance Metrics of models with null true effect 
 
True effect=0, 𝜆0=0.01, sample size=500, censor rate=0.904 
Models Bias %bias StDev SE MSE Coverage 
Marginal Cox Model 
w 0.064 NA 0.968 0.697 0.941 0.844 
sw 0.025 NA 0.326 0.329 0.107 0.950 
swc 0.025 NA 0.327 0.331 0.108 0.950 
Time dependent Cox Model 
     Baseline L0 0.338 NA 0.298 0.296 0.203 0.804 
Time dependent Lm 0.293 NA 0.300 0.296 0.176 0.834 
True effect=0, 𝜆0=0.01, sample size=2500, censor rate=0.904 
Marginal Cox Model 
 w 0.008 NA  0.416 0.390 0.173 0.944 
sw 0.007 NA  0.152 0.146 0.023 0.942 
swc 0.008 NA 0.153 0.147 0.024 0.936 
Time dependent Cox Model 
     Baseline L0 0.332 NA  0.131 0.130 0.127 0.286 
Time dependent Lm 0.283 NA  0.132 0.131 0.098 0.444 
True effect=0, 𝜆0=0.1, sample size=500, censor rate=0.369 
Marginal Cox Model 
w 0.025 NA  0.478 0.391 0.229 0.880 
sw 0.008 NA  0.125 0.122 0.016 0.950 
swc 0.009 NA 0.124 0.122 0.016 0.954 
Time dependent Cox Model 
     Baseline L0 0.042 NA  0.118 0.115 0.016 0.926 
Time dependent Lm 0.039 NA  0.118 0.115 0.015 0.936 
True effect=0, 𝜆0=0.1, sample size=2500, censor rate=0.368 
Marginal Cox Model 
w 0.001 NA  0.207 0.199 0.043 0.942 
sw 0.000 NA  0.057 0.054 0.003 0.942 
swc 0.000 NA 0.057 0.054 0.003 0.944 
Time dependent Cox Model 
     Baseline L0 0.035 NA  0.054 0.051 0.004 0.878 
Time dependent Lm 0.031 NA  0.054 0.051 0.004 0.896 
 
Note: w refers to un-stabilized weight; sw is stabilized weight; swc is stabilized 
weight considering censoring. StDev is empirical standard deviations. 
 
 
22 
 
Table 3.3 Performance Metrics of models with true effect being 0.3 
 
True effect=0.3, 𝜆0=0.01, sample size=500, censor rate=0.888 
Models Bias %bias StDev SE MSE Coverage 
Marginal Cox Model 
     w 0.075 24.867 0.868 0.667 0.759 0.862 
sw 0.003 1.004 0.317 0.310 0.100 0.952 
swc 0.004 1.324 0.318 0.312 0.101 0.952 
Time dependent Cox Model 
    Baseline L0 0.334 111.336 0.288 0.278 0.194 0.784 
Time dependent Lm 0.283 94.348 0.287 0.279 0.163 0.828 
True effect=0.3, 𝜆0=0.01, sample size=2500, censor rate= 0.888 
Marginal Cox Model 
     w 0.009 3.164 0.442 0.376 0.195 0.894 
sw 0.005 1.811 0.140 0.138 0.020 0.952 
swc 0.006 2.130 0.140 0.139 0.020 0.950 
Time dependent Cox Model 
    Baseline L0 0.335 111.590 0.122 0.123 0.127 0.214 
Time dependent Lm 0.284 94.806 0.123 0.123 0.096 0.366 
       
True effect=0.3, 𝜆0=0.1, sample size=500, censor rate= 0.306 
Marginal Cox Model 
     w 0.008 2.773 0.440 0.386 0.194 0.914 
sw 0.002 0.558 0.126 0.117 0.016 0.926 
swc 0.002 0.706 0.126 0.117 0.016 0.926 
Time dependent Cox Model 
    Baseline L0 0.038 12.555 0.117 0.110 0.015 0.926 
Time dependent Lm 0.034 11.280 0.117 0.111 0.015 0.934 
True effect=0.3, 𝜆0=0.1, sample size=2500, censor rate= 0.307 
Marginal Cox Model 
     w -0.007 -2.196 0.217 0.194 0.047 0.928 
sw -0.002 -0.770 0.053 0.052 0.003 0.952 
swc -0.002 -0.706 0.053 0.052 0.003 0.956 
Time dependent Cox Model 
    Baseline L0 0.033 11.157 0.049 0.049 0.004 0.896 
Time dependent Lm 0.030 9.928 0.050 0.049 0.003 0.908 
 
Note: w refers to un-stabilized weight; sw is stabilized weight; swc is stabilized 
weight with censoring. StDev is empirical standard deviations. 
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Table 3.4 Performance Metrics of models with true effect being -0.3 
 
True effect=-0.3, 𝜆0=0.01, sample size=500, censor rate= 0.916 
Models Bias %bias StDev SE MSE Coverage 
Marginal Cox Model 
w 0.094 31.365 1.006 0.725 1.021 0.834 
sw 0.006 -2.067 0.357 0.354 0.127 0.960 
swc 0.007 -2.208 0.358 0.355 0.128 0.956 
Time dependent Cox Model 
     Baseline L0 0.331 -110.373 0.323 0.319 0.214 0.814 
Time dependent Lm 0.280 -93.411 0.322 0.320 0.182 0.864 
True effect=-0.3, 𝜆0=0.01, sample size=2500, censor rate= 0.917 
Marginal Cox Model 
 w 0.013 -4.197 0.474 0.414 0.225 0.914 
sw 0.002 0.584 0.163 0.158 0.026 0.938 
swc 0.001 0.411 0.164 0.159 0.027 0.936 
Time dependent Cox Model 
     Baseline L0 0.319 -106.379 0.146 0.141 0.123 0.376 
Time dependent Lm 0.270 -90.109 0.146 0.142 0.094 0.538 
True effect=-0.3, 𝜆0=0.1, sample size=500, censor rate= 0.422 
Marginal Cox Model 
w 0.020 6.692 0.467 0.400 0.218 0.900 
sw 0.001 0.316 0.133 0.129 0.018 0.952 
swc 0.001 0.385 0.133 0.129 0.018 0.952 
Time dependent Cox Model 
     Baseline L0 0.031 -10.222 0.123 0.121 0.016 0.946 
Time dependent Lm 0.027 -8.882 0.123 0.121 0.016 0.944 
True effect=-0.3, 𝜆0=0.1, sample size=2500, censor rate= 0.422 
Marginal Cox Model 
w 0.004 1.171 0.209 0.203 0.044 0.942 
sw 0.000 -0.118 0.054 0.057 0.003 0.966 
swc 0.000 -0.133 0.054 0.057 0.003 0.968 
Time dependent Cox Model 
     Baseline L0 0.033 -10.972 0.050 0.054 0.004 0.926 
Time dependent Lm 0.029 -9.715 0.050 0.054 0.003 0.938 
 
Note: w refers to un-stabilized weight; sw is stabilized weight; swc is stabilized 
weight considering censoring. StDev is empirical standard deviations. 
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To summarize, First, the estimate from the time dependent Cox model using 
time-varying confounders was better than the estimate from model using baseline 
confounders. Although the time-dependent Cox model is commonly used in practice, 
the estimates remained biased when there was treatment confounder feedback based 
on the simulation results.  
Second, when there is treatment confounder feedback, the marginal structural 
Cox model should be applied to get unbiased estimates of the casual inference effect. 
Estimates with stabilized weights had smaller bias and variability, and larger coverage 
probability than those using un-stabilized weights. When existence of informative 
censoring, estimates with the stabilized weight considering censoring are expected to 
perform better than those without considering censoring. 
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CHAPTER 4. ACLS DATA 
Hypertension is a very common chronic disease and affects the health of 
numerous people. The risk of developing high blood pressure includes, age, race, 
family history, being overweight or obese, not being physical active, smoking, too much 
sodium diet, too little potassium in diet, heavy drinking, stress and some chronic 
diseases. (13) 
Cardiorespiratory fitness (CRF) measures the ability of the circulatory and 
respiratory systems to supply oxygen to skeletal muscles during sustained physical 
activity. Studies have shown that CRF is inversely associated with the risk of 
hypertension. (14, 15) 
Both CRF and overweight can work as independent risk factors of hypertension. 
Increased CRF level which caused by increased physical activity can help reduce body 
fat percentage, body mass index (BMI), thus improve overweight or obese status. The 
reduced BMI also help increase cardiorespiratory fitness level subsequently. Therefore, 
there exists a treatment-confounder feedback. That is, CRF-overweight feedback. 
In this study, we want to explore that effect of CRF on hypertension incidence 
by using the marginal structural Cox model. 
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4.1 DATASET DESCRIPTION 
Started in 1970, the Aerobics Center Longitudinal Study (ACLS) is a 
prospective cohort study aiming to investigate health outcomes associated with 
cardiorespiratory fitness and physical activity. In our study, 14290 participants who 
have completed a baseline examination at the Cooper Clinic (Dallas, Texas) during 
1974–2003 were included. All participants were free of hypertension at baseline; at 
least 2 visits are available for each subject; they were able to achieve at least 85% of 
age-predicted maximal heart rate (220 minus age in years) at each visit; were free of 
history of heart attack, stroke, cancer, and abnormal ECG at baseline; subjects whose 
BMI less than 18.5 or greater than 80 were excluded; all have complete data on 
blood pressure, glucose, cholesterol, fitness, and BMI. 
The study protocol was approved annually by the Institutional Review Board of 
the Cooper Institute and all participants provided written consent to participate in this 
follow-up study. 
Exposure/ Treatment 
Cardiorespiratory fitness (CRF) level was assessed as the duration of a 
symptom-limited maximal treadmill exercise test using a modified Balke protocol. (16, 
17) The treadmill speed was 88 m∙min-1 for the first 25 min. During this time, the grade 
was 0% for the first minute, 2% the second minute and increased 1% for each minute. 
After 25 min, the grade remained constant while the speed increased 5.4 m∙min-1 each 
minute until test termination. Patients were encouraged to give a maximal effort 
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during the test. Maximal metabolic equivalents (METs, 1 MET = 3.5 ml O2 uptake ∙ kg −1 
∙ min −1) were estimated from the final treadmill speed and grade. Maximal treadmill 
time was measured in minutes. 
Subjects were divided into 3 groups, low (lowest 20%), middle (middle 40%) 
and high (upper 20%), according to the quantile of maximal treadmill time in each sex- 
and age-group (20-39, 40-49, 50-59, 60+) specific distribution from the overall ACLS 
population. The exposure or treatment was time-varying. 
Outcome and censoring 
All participants were followed from the date of their baseline examination until 
their occurrence of hypertension or December 31, 2003. Hypertension was defined as 
physician diagnosed high blood pressure or blood pressure >=140/90 mmHg. If a 
subject was diagnosed as hypertension, then the event occurs. While if a subject 
remained not being diagnosed as hypertension at the end of study, then this person 
was defined as censored. In log format data structure, the start and end of visits were 
from 0-1, 1-2, 2-3, …, until 25-26. 
Confounders 
The baseline clinical examination included anthropometry, resting blood 
pressure and ECG, fasting blood chemistry analysis, personal and family health history, 
and a maximal graded exercise test. Examination methods and procedures followed a 
standard manual of operations, as described previously. (16) 
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After checking the value of variables, sex and family history of hypertension 
were treated as fixed confounders. Since age, BMI, diabetes, hypercholesterolemia, 
smoking and heavy drinking changed their values during follow-up, they were treated 
as time-varying confounders.  
If participants reported the parental hypertension during all study periods, the 
family history of hypertension of this participant was defined as ‘Yes’. Otherwise, ‘No’. 
Body mass index [BMI = weight (kg) / height (m) 2] was computed from measured 
height and weight. Overweight or obese was defined if the BMI > 25 Kg/m2. Diabetes 
was defined as physician diagnosed diabetes, insulin use, or glucose>=126 mg/dL; and 
hypercholesterolemia was defined as by total cholesterol ≥240 mg/dl, or physician 
diagnosed hypercholesterolemia. Information on smoking habits (current smoker or 
not), heavy drink (alcohol drinks >14 per week or not) was obtained from a 
standardized questionnaire. 
4.2 ANALYSIS USING MARGINAL STRUCTURAL COX MODEL 
4.2.1 Data Preparation 
Data were organized into long format as described in Chapter 3. Each subject 
had at least 2 rows of observations. Variables list were ID, number of visit, start of each 
visit, end of each visit, occurrence of hypertension, censor indicator, time dependent 
variables (CRF levels, overweight or obese, age, diabetes, hypercholesterolemia, 
smoking and heavy drinking status), time independent variables (sex and family history 
of hypertension), and history of previous CRF levels. 
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Means and standard deviation were used to describe the baseline continuous 
variables. Frequency and proportion was used to describe discrete variables. Baseline 
differences between three CRF groups were tested using ANOVA and Chi square test.  
4.2.2 IP Weights And Marginal Structural Cox Model 
Calculation of IP weights was as we described in Chapter 3. Specific, a 
cumulative logit model to the ordinal data was fitted to estimate the numerator of 
𝑠𝑤𝑚
𝑇. The history of exposure is the previous CRF level (low CRF is the reference 
group). Covariates includes sex, family history of hypertension, BMI, age, smoking and 
heavy drinking status, diabetes and hypercholesterolemia). Here, only baseline 
covariates L0  were used. 
Model 1: cumlogit (CRFj ) = CRF_middlej−1 + CRF_highj−1 + L0 
Model 2 was used to estimate the denominator of 𝑠𝑤𝑚
𝑇. The time-varying 
covariates Lj were included. cumlogit (CRFj ) = CRF_middlej−1 + CRF_highj−1 + Lj 
Following the methods described in Chapter 3, prediction of fitness level was 
estimated from model 1 and 2; the stabilized time-varying weights, 𝑠𝑤𝑚
𝑇  was 
calculated.  
The marginal Cox model was estimated using Coxph() function in the R package 
survival. The time-dependent Cox models using baseline covariates and time-varying 
covariates were also fitted. The estimated parameters from the marginal structural 
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Cox model can be explained as the causal effects of cardiorespiratory fitness on 
hypertension incidence. Robust variance estimates were obtained. 
4.2.3 Results 
Baseline characteristics are shown in Table 4.1. Among the total 14,290 
participants, there were 1,280 subjects in low CRF group, 5,079 in middle group and 
7,931 in high CRF group. Subjects who had higher CRF were elder, had less body 
weight, BMI, lower blood pressure and total cholesterol. The maximal METs and 
treadmill time duration were higher with increasing CRF level. People in high CRF 
group had large proportions of women, not current smokers, not diagnosed with 
diabetes and hypercholesterolemia. The proportions of heavy drinking and family 
history of hypertension were the highest in high CRF group. 
Table 4.1 Descriptive statistics of baseline variables in ACLS study 1974-2003 
Variables 
Low CRF 
(n=1280) 
Middle CRF 
(n=5079) 
High CRF 
(n=7931) p value 
Age (year) 41.5±41.1 42.5±42.3 43.7±43.6 <.0001 
Weight (Kg) 86.8±86 81±80.7 75.9±75.6 <.0001 
Body mass index (Kg/m2) 27.8±27.6 25.8±25.7 24.2±24.2 <.0001 
Maximal METs  8.7±8.6 10.6±10.6 13.3±13.2 <.0001 
Treadmill time duration (min) 11.6±11.4 15.7±15.7 21.3±21.2 <.0001 
Systolic blood pressure (mm Hg) 116.3±115.9 115.5±115.2 115.4±115.2 0.0105 
Diastolic blood pressure (mm Hg) 77.8±77.5 77±76.8 76.3±76.2 <.0001 
Total cholesterol (mg/dL) 212.7±210.9 207.2±206.3 200.4±199.4 <.0001 
Fasting blood glucose (mg/dL) 100.7±99.9 98.1±97.7 98.9±96.2 0.7303 
Female (%) 13.52 15.57 19.58 <.0001 
Current smoker (%) 29.38 18.67 9.39 <.0001 
Heavy drink (>14 per week, %) 4.92 5.55 7.7 <.0001 
Diabetes (%) 7.27 4.11 2.71 <.0001 
Hypercholesterolemia (%) 28.67 24.59 20.05 <.0001 
Family history of hypertension (%) 17.81 23.13 28.08 <.0001 
 
31 
 
All participants had at least 2 visits. More than a half had three to five visits. 
And near 4% subjects were followed up for over 10 visits. 3869 (27.1%) subjects had 
hypertension occurred during follow-up and 77.9% of subjects were censored. (Please 
see Table 4.2) 
Table 4.2 Characteristics of ACLS follow-up 
 
Characteristics Frequency and proportion 
Time of visits 
 2 14290 (100%) 
3-5 7404 (51.8%) 
6-10 2158 (15.1%) 
≥11 532 (3.7%) 
Hypertension occurrence counts 3869 (27.1%) 
Censoring 11132 (77.9%) 
 
 
The marginal structural Cox model with un-stabilized weights did not converge. 
The estimates using the stabilized weights can be explained as: taking people who 
were continuously in CRF low group as reference, the hazard of hypertension was of 
no significant different from those who were continuously in CRF middle group. There 
was on average a 23% decrease in hazard of hypertension among subjects who were 
always in CRF high group. The 95% CI was 5%-38%. (Table 4.3) 
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Table 4.3 Hazard ratios and 95% confidence intervals from the marginal structural 
Cox model using stabilized weight 
 
Variables Hazard ratios and 95% CIs Pr 
CRF middle 1.11 (0.83-1.48) 0.4985 
CRF high 0.77 (0.62-0.95) 0.0158 
Overweight/obese 1.55 (1.33-1.80) <.0001 
Age 1.02 (1.01-1.03) <.0001 
Sex (Female) 0.42 (0.20-0.92) 0.0297 
Family history of hypertension 1.20 (1.01-1.42) 0.0431 
Smoking 0.95 (0.78-1.16) 0.6322 
Heavy drinking 1.19 (1.01-1.39) 0.0337 
diabetes 0.75 (0.51-1.10) 0.1378 
hypercholesterolemia 1.04 (0.90-1.20) 0.5811 
 
 
4.3 COMPARING RESULTS OF DIFFERENT MODELS 
4.3.1 The Time-Dependent Cox Model 
One common approach is to fit a time dependent Cox model using baseline 
covariates. We can also fit another model using time-varying confounders. In this part, 
I will compare the estimates resulting from different models. 
4.3.2 Results Comparisons 
Results shown in Table 4.4 were from the time dependent Cox model using 
baseline covariates. After controlling for other covariables at baseline, the hazard ratio 
of hypertension was 0.79 (0.68-0.91) for middle CRF group and 0.62 (0.53-0.71) for 
high CRF group.  
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Table 4.4 Results of the time-dependent Cox PH model using baseline covariates 
 
Variables Hazard ratios and 95% CIs Pr 
CRF middle 0.79 (0.68-0.91) 0.0015 
CRF high 0.62 (0.53-0.71) <.0001 
Overweight/obese 1.33 (1.24-1.42) <.0001 
Age 1.02 (1.02-1.03) <.0001 
Sex (Female) 0.66 (0.60-0.73) <.0001 
Family history of hypertension 1.16 (1.08-1.24) <.0001 
Smoking 0.87 (0.80-0.95) 0.0026 
Heavy drinking 1.19 (1.05-1.34) 0.0064 
diabetes 0.94 (0.81-1.08) 0.376 
hypercholesterolemia 1.05 (0.98-1.13) 0.1548 
 
 
Results of the time-dependent Cox model using time-varying covariates shown 
that comparing to participants in low cardiorespiratory fitness level, those in middle 
and high CRF group had reduced risk of hypertension, the hazard ratios and 95% CIs 
being 0.79 (0.68-0.92) and 0.64 (0.56-0.74), respectively. 
In addition, except the effect of hypercholesterolemia, the hazard ratios of 
other covariates of these two time-dependent models were also similar. Being 
overweight or obese, getting elder, with family history of hypertension and drinking 
heavily were significantly associated with the increased hazard of hypertension. While 
women had lower risk of developing hypertension than men, when controlling for 
other covariates in this study. The effect of high cholesterol on hypertension was 
detected in the time-dependent Cox model using time-varying covariates. However, 
the estimate effect of smoking was not as what we expected. The effect estimate of 
smoking on hypertension was not significant in the marginal structural Cox model. 
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Table 4.5 Results of time-dependent Cox PH model using time-varying covariates 
Variables Hazard ratios and 95% CIs Pr 
CRF middle 0.79 (0.68-0.92) 0.0019 
CRF high 0.64 (0.56-0.74) <.0001 
Overweight/obese 1.61 (1.50-1.72) <.0001 
Age 1.04 (1.03-1.04) <.0001 
Sex (Female) 0.67 (0.61-0.75) <.0001 
Family history of hypertension 1.13 (1.06-1.21) 0.0002 
Smoking 0.73 (0.66-0.82) <.0001 
Heavy drinking 1.45 (1.30-1.62) <.0001 
diabetes 0.99 (0.82-1.18) 0.8885 
hypercholesterolemia 1.25 (1.17-1.34) <.0001 
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CHAPTER 5. DISCUSSION AND CONCLUSION 
Results of the two time-dependent Cox models were similar, which indicated 
that in this ACLS data, the changing of covariates didn't affect the estimations a lot. 
Although estimates from these two models were statistically significant, they didn't 
have the causal interpretations since there was treatment confounder feedback. When 
there is no treatment confounder feedback, estimates of effect can be obtained from 
the time-dependent Cox model. 
To address exposure-confounder feedback, inverse probability weights were 
calculated and applied into the marginal structural Cox model. In this study, there was 
significant decrease of hazard of hypertension for people who were always in high CRF 
comparing to those who were always in low CRF group. These estimates assumed that 
only the cardiorespiratory fitness of the previous visit had direct impact on the current 
CRF level. 
The validity of effect estimates depends on assumptions of no measurement 
errors and no model misspecification. (18) These two conditions are hard to realize in 
the observational studies. For example, family history of hypertension was defined as 
any reported parental hypertension during follow-up period. Parental hypertension 
can be diagnosed several years after subjects entered into this study. 
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Therefore, the family history of hypertension may be underestimated. When 
calculating the IP weights, there are possibility of having model misspecification. If the 
unmeasured confounders had significant effect on the levels of exposure or affect the 
censoring status, then the calculated IP weights can't remove all confounding. Under 
this circumstance, the estimates of casual effect would be biased. 
In a clinical trial, participants would be re-visited after a certain amount of time, 
such as 3 months. The time interval between two visits would be regular. However, in 
the ALCS study, the follow-up was not based on the same intervals. For example, after 
a subject entering into study, the second visit was 2 years later, the third visit was 5 
years after. Ignoring different visit intervals and only using information of number of 
visit, assumes that the effect of overweight status at visit 1 on visit 2 (2 years ago) is 
same as the effect of overweight at visit 2 on visit 3 (5 years ago), which is not 
biologically reasonable. Considering the durations between visits can improve the 
calculation of the inverse probability weight. 
The Ipw R package has function ipwtm() to estimate time-varying inverse 
probability weights. The exposure can be binomial, multinomial, ordinal or continuous. 
Estimation of weights can be calculated by using all visits, or only visits until the 
exposure level first switches form one level to another. After this switch, weights are 
held constant. Currently, only for binary exposure, all visits can be used.  For some 
clinical trials where after patients initiating the new treatment, they will keep taking it. 
In this case, it makes sense that weights calculated until the first switch and are 
constant for the rest visits. However, in the ACLS data, the level of cardiorespiratory 
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fitness can change during the whole follow-up. The ipwtm() function can't be used to 
calculate the time-varying weights. Further work should be done to expand this R 
package to support such data.  
In conclusion, to get unbiased estimates of causal effects from the 
observational study, exchangeability, positivity, consistency, no measurement error 
and no model misspecification need to be hold. Marginal Cox model can be applied in 
longitudinal data to deal with the treatment-confounder feedback. Estimates and 
variance with stabilized weights perform better than the un-stabilized weights. 
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APPENDIX A SOURCE CODES 
SAS code, calculating IP weights: 
%macro weight(); 
/* Model 1 */ 
proc logistic data=sim desc noprint; 
        model A = am1; 
        output out=tr_top p=ptr_num; 
run; 
/* Model 2 */ 
proc logistic data=sim desc noprint; 
        model A = am1 l lm1; 
        output out=tr_bot p=ptr_den; 
run; 
/* Model 3 */ 
proc logistic data=sim noprint; 
        model censor_r = am1; 
 output out=cen_top p=pcen_num; 
run; 
/* Model 4 */ 
proc logistic data=sim noprint; 
        model censor_r = am1 lm1 lm2; 
 output out=cen_bot p=pcen_den; 
run; 
proc sort data=tr_top; by id tpoint; run; 
proc sort data=tr_bot; by id tpoint; run; 
proc sort data=cen_top; by id tpoint; run; 
proc sort data=cen_bot; by id tpoint; run; 
data main_w; 
        merge tr_top tr_bot cen_top cen_bot; 
        by ID tpoint; 
if a=1 then ptr_num=ptr_num; 
if a=0 then ptr_num=1-ptr_num; 
if a=1 then ptr_den=ptr_den; 
if a=0 then ptr_den=1-ptr_den; 
if first.id then do;  
tr_num=1;
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tr_den=1; 
cen_num=1; 
cen_den=1; 
end; 
retain tr_num tr_den cen_num cen_den; 
tr_num=tr_num*ptr_num; 
tr_den=tr_den*ptr_den; 
cen_num=cen_num*pcen_num; 
cen_den=cen_den*pcen_den; 
 
wc=1/(tr_den*cen_den); 
swc=(tr_num*cen_num)/(tr_den*cen_den); 
w=1/(tr_den); 
sw=(tr_num)/(tr_den); 
run; 
%mend; 
/*%weight();*/ 
%macro data(n=, subjects=,   psi1= , lam=, out=); 
%let c=1; 
%do i=1 %to &n; 
%simulate(subjects=&subjects,  psi1=&psi1 , lam=&lam); 
%weight(); 
proc export data=main_w 
   outfile=%unquote(%str(%')C:\sim\&out\a&c%str(.)csv%str(%')) 
   dbms=csv 
   replace; 
run; 
%let c=%eval(&c+1); 
%end; 
%mend; 
%data(n=500, psi1=0 , lam=0.01, subjects=500,  out=p00_lmd001_n500); 
%data(n=500, psi1=0 , lam=0.1, subjects=500,  out=p00_lmd01_n500); 
%data(n=500, psi1=0 , lam=0.01, subjects=2500,  out=p00_lmd001_n2500); 
%data(n=500, psi1=0 , lam=0.1, subjects=2500,  out=p00_lmd01_n2500); 
%data(n=500, psi1=-0.3 , lam=0.01, subjects=500,  out=p-03_lmd001_n500); 
%data(n=500, psi1=-0.3 , lam=0.1, subjects=500,  out=p-03_lmd01_n500); 
%data(n=500, psi1=-0.3 , lam=0.01, subjects=2500,  out=p-03_lmd001_n2500); 
%data(n=500, psi1=-0.3 , lam=0.1, subjects=2500,  out=p-03_lmd01_n2500); 
R code, fitting marginal Cox models:  
library('survival') 
simu<-500 #1fixed number 
truev<- 0 #2true treatment effect, fai 
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est<-matrix(0, simu,9) 
est1<-matrix(0, simu,6) 
for(i in 1:simu){ 
x <- read.csv(paste("C:/sim/p00_lmd001_n500/a", i, ".csv", sep=""))#3location  
a <- subset(x, tpoint==1, select = c(id, L)) 
a$L0 <-a$L 
a <- subset(a, select=c(id, L0)) 
x <-merge(x, a, by = "id") 
m1<-CoxPH(Surv(tpoint2,tpoint,Y)~A+cluster(id), data=x, weights=w) 
m2<-CoxPH(Surv(tpoint2,tpoint,Y)~A+cluster(id), data=x, weights=wc) 
m3<-CoxPH(Surv(tpoint2,tpoint,Y)~A+cluster(id), data=x, weights=sw) 
m4<-CoxPH(Surv(tpoint2,tpoint,Y)~A+cluster(id), data=x, weights=swc) 
est[i,c(1,2)] <- c(m1$coef,m1$var) 
est[i,c(3,4)] <- c(m2$coef,m2$var) 
est[i,c(5,6)] <- c(m3$coef,m3$var) 
est[i,c(7,8)] <- c(m4$coef,m4$var) 
est[i,9] <- sum(x$Y)/500 #4number of id, 500 or 2500 
m5<-CoxPH(Surv(tpoint2,tpoint,Y)~A+L0+cluster(id), data=x) 
m6<-CoxPH(Surv(tpoint2,tpoint,Y)~A+L+cluster(id), data=x) 
m7<-CoxPH(Surv(tpoint2,tpoint,Y)~A+L+Lm1+cluster(id), data=x) 
est1[i,c(1,2)] <- c(m5$coef[1],m5$var[1,1]) 
est1[i,c(3,4)] <- c(m6$coef[1],m6$var[1,1]) 
est1[i,c(5,6)] <- c(m7$coef[1],m7$var[1,1]) 
} 
betabar<-c (mean(est[,1]),mean(est[,3]),mean(est[,5]),mean(est[,7])) 
emp_sd<-c(sqrt(var(est[,1])),sqrt(var(est[,3])),sqrt(var(est[,5])),sqrt(var(est[,7]))) 
sd <-c (mean(est[,2]),mean(est[,4]),mean(est[,6]),mean(est[,8])) 
bias<-betabar-truev 
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per_bias<-100*bias/truev 
#std_bias<-100*bias/betastd 
MSE<-bias^2+emp_sd^2 
coverage<-c( 
sum(as.numeric((truev<est[,1]+qnorm(0.975)*sqrt(est[,2]) & truev>est[,1]-
qnorm(0.975)*sqrt(est[,2]))))/simu , 
sum(as.numeric((truev<est[,3]+qnorm(0.975)*sqrt(est[,4]) & truev>est[,3]-
qnorm(0.975)*sqrt(est[,4]))))/simu ,  
sum(as.numeric((truev<est[,5]+qnorm(0.975)*sqrt(est[,6]) & truev>est[,5]-
qnorm(0.975)*sqrt(est[,6]))))/simu , 
sum(as.numeric((truev<est[,7]+qnorm(0.975)*sqrt(est[,8]) & truev>est[,7]-
qnorm(0.975)*sqrt(est[,8]))))/simu 
) 
censor_rate<- 1-mean(est[,9]) 
